HOUSE 4626118th CongressReferred to the Subcommittee on Health.

OTC Act of 2023

Last Action: 7/14/2023

Actions

2023-07-14Referred to the Subcommittee on Health.
2023-07-13Referred to the House Committee on Energy and Commerce.
2023-07-13Introduced in House
2023-07-13Introduced in House

CRS Summary

As of 2023-07-13 (00)

Orally Taken Contraception Act of 2023 or the OTC Act of 2023

This bill requires the Food and Drug Administration (FDA) to issue guidance on the approval process for over-the-counter oral contraceptives so as to encourage drug manufacturers to submit applications for approval. The FDA must also evaluate (1) whether and to what extent consumers understand the labeling on oral contraceptives, and (2) whether the labeling could be improved.

Cosponsors (10)

Jennifer Kiggans (R-VA)
Marjorie Greene (R-GA)
Stephanie Bice (R-OK)
Maria Salazar (R-FL)
Lori Chavez-DeRemer (R-OR)
Nicole Malliotakis (R-NY)
Young Kim (R-CA)
Diana Harshbarger (R-TN)
Nancy Mace (R-SC)
Ashley Hinson (R-IA)

Subjects

Drug safety, medical device, and laboratory regulation
Family planning and birth control
Government information and archives
Government studies and investigations
Prescription drugs
Women's health

Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.